Published by Alexander Bueso on 16th May 2022
(Sharecast News) - Shares of Synairgen caught a bid following the release of clinical trial results which appeared to show that its SNG001 formulation against Covid-19 might lower the risk of severe disease or death in the most at risk patients.
URL: http://www.digitallook.com/dl/news/story/32680720/...